Kiromic BioPharma appoints Brian Hungerford as interim CFO

Kiromic Biopharma, Inc.

Appointed Brian Hungerford as interim Chief Financial Officer effective June 12, 2023.
Mr. Hungerford was retained through an agreement with Element 78 Partners, LLC.
No departure of prior CFO or other officers was disclosed.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed (interim)

Brian Hungerford

interim Chief Financial Officer

Kiromic Biopharma, Inc.

Effective: 2023-06-12
Filed: June 12, 2023, 7:59 PM ET

On June 12, 2023, Kiromic BioPharma, Inc. (the "Company") appointed Brian Hungerford as interim Chief Financial Officer of the Company.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Brian Hungerford was appointed as interim Chief Financial Officer at Kiromic Biopharma, Inc..

Action: appointed
Role: interim Chief Financial Officer

Exact text from the filing

On June 12, 2023, Kiromic BioPharma, Inc. (the "Company") appointed Brian Hungerford as interim Chief Financial Officer of the Company.

View on SEC.gov

Source: SEC EDGAR

accession 0001104659-23-070367

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.